Nyxoah SA. | WebDisclosure

Basculer en Français

8227	Companies
111057	Keywords
52775	Articles
60952	Press releases

Home
Companies
Nyxoah SA.

BRIEF

published on 11/06/2024 at 22:10, 1 day 15 hours ago

Nyxoah publie ses résultats financiers du troisième trimestre 2024

Résultats Financiers Approbation De La FDA Situation De Trésorerie Apnée Obstructive Du Sommeil Commercialisation Aux États-Unis
BRIEF

published on 11/06/2024 at 22:10, 1 day 15 hours ago

Nyxoah Reports Third Quarter 2024 Financial Results

Financial Results Cash Position FDA Approval Obstructive Sleep Apnea U.S. Commercialization
PRESS RELEASE

published on 11/06/2024 at 22:05, 1 day 15 hours ago

Nyxoah Reports Third Quarter Financial and Operating Results
Nyxoah SA reports third quarter financial and operating results, with FDA approval on track for Q1 2025 and strengthening of U.S. commercial team. Company fully funded until mid-2026

Financial Results FDA Approval Sleep Apnea Nyxoah U.S. Commercial Team
BRIEF

published on 10/08/2024 at 14:05, 30 days 23 hours ago

Nyxoah obtient 27 millions de dollars lors d'une offre sur le marché

Financement Marché Américain Nyxoah Neuromodulation Investisseur Dans Le Secteur De La Santé
BRIEF

published on 10/08/2024 at 14:05, 30 days 23 hours ago

Nyxoah Secures $27 Million in At-the-Market Offering

Financing U.S. Market Nyxoah Neuromodulation Healthcare Investor
PRESS RELEASE

published on 10/08/2024 at 14:00, 30 days 23 hours ago

Nyxoah Raises $27 Million through its At-the-Market Offering
Nyxoah raises $27 million through its At-the-Market Offering, strengthening balance sheet and U.S. focus. New investment from U.S. healthcare investor

Financing At-the-market Offering Nyxoah Obstructive Sleep Apnea Healthcare Investor
BRIEF

published on 09/27/2024 at 22:35, 1 month 10 days ago

Nyxoah présente les données prometteuses de l'étude DREAM à l'ISSS 2024

Approbation De La FDA Apnée Obstructive Du Sommeil Données Cliniques Étude DREAM Stimulation Génio
BRIEF

published on 09/27/2024 at 22:35, 1 month 10 days ago

Nyxoah Presents Promising DREAM Study Data at ISSS 2024

FDA Approval Clinical Data Obstructive Sleep Apnea DREAM Study Genio Stimulation
PRESS RELEASE

published on 09/27/2024 at 22:30, 1 month 10 days ago

DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Nyxoah presents DREAM Study results at the International Surgical Sleep Society 2024 Educational Update, showing significant improvements in OSA patients treated with Genio neuromodulation therapy

Clinical Data Nyxoah Obstructive Sleep Apnea DREAM Study Neuromodulation
BRIEF

published on 09/02/2024 at 22:10, 2 months 5 days ago

Nyxoah sonne la cloche de clôture du Nasdaq tout en se préparant au lancement sur le marché américain d'un dispositif innovant contre l'apnée du sommeil

Approbation De La FDA Apnée Du Sommeil Nyxoah Lancement Sur Le Marché Américain Appareil Genio®

Accesswire

Published on 11/08/2024 at 13:05, 6 minutes ago

Aton Announces Corporate and Operations Update
Published on 11/08/2024 at 13:00, 11 minutes ago

Honey Badger Announces Change of Transfer Agent
Published on 11/08/2024 at 13:00, 11 minutes ago

NioCorp Provides Preliminary Financial Results for the Three Months Ended September 30, 2024
Published on 11/08/2024 at 13:00, 11 minutes ago

Velocity One Signs Merger Agreement With EMCORE (EMKR)
Published on 11/08/2024 at 12:30, 41 minutes ago

Jaguar Mining Reports Financial Results for the Third Quarter 2024

View all ACCESSWIRE

EQS Group

Published on 11/08/2024 at 12:31, 40 minutes ago

Original-Research: ORBIS SE (von GSC Research GmbH): Kaufen
Published on 11/08/2024 at 12:30, 41 minutes ago

Holding(s) in Company
Published on 11/08/2024 at 12:25, 46 minutes ago

freenet Executive Board formulates financial ambition until 2028 - EBITDA and free cash flow to grow significantly
Published on 11/08/2024 at 12:11, 1 hour ago

PNE AG selected by the European Commission for funding a project to produce hydrogen
Published on 11/08/2024 at 12:01, 1 hour 9 minutes ago

EQS-Adhoc: Borussia Dortmund reports preliminary figures for the first quarter (Q1) of the 2024/2025 financial year

Les Echos

Published on 11/08/2024 at 12:32, 39 minutes ago

Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:32, 39 minutes ago

Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 56 minutes ago

Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 56 minutes ago

Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 08:00, 5 hours 11 minutes ago

DAMARTEX / Droits de vote bruts et réels 31 octobre 2024

View all LES ECHOS COMFI WIRE